Obruca A, Strohmer H, Brunner M, Kindermann C, Feichtinger W
Institut für Sterilitätsbetreuung Wien.
Geburtshilfe Frauenheilkd. 1995 Jul;55(7):400-3. doi: 10.1055/s-2007-1022809.
Poor function of spermatozoa accounts for half of all human infertility. "Intracytoplasmic sperm injection" (ICSI) is a new micromanipulatory method for the treatment of male infertility. "ICSI" was performed in cases of oligoasthenozoospermia in 12 IVF cycles, obtaining a fertilisation rate of 71.2% of all micromanipulated oocytes. So far four ongoing pregnancies occurred. Thus "Intracytoplasmic sperm Injection" represents a new encouraging technique to conceive, even in cases of severe male infertility.
精子功能不佳占人类所有不孕症的一半。“卵胞浆内单精子注射”（ICSI）是一种治疗男性不育症的新型显微操作方法。在12个体外受精周期中，对少弱精子症患者实施了ICSI，所有显微操作的卵母细胞的受精率为71.2%。到目前为止，已有4例持续妊娠。因此，即使在严重男性不育的情况下，“卵胞浆内单精子注射”也是一种新的、令人鼓舞的受孕技术。
